Concordant with our data, Want et al recently implicated miR-320 in chemo-sensitivity by targeting FOXM1 in vitro, a critical gene which plays a principle role in colon, lung, and breast cancer tumor initiation and progression [26–28]. This evidence concerns the gene FOXM1 and neoplasm.